• 1
    Katz GA, Peter JB, Pearson CM, Adams WS. The shoulder-pad sign — a diagnostic feature of amyloid arthropathy. N Engl J Med 1973;288:3545.
  • 2
    Gertz MA & Kyle RA. Primary systemic amyloidosis — a diagnostic primer. Mayo Clin Proc 1989;64:150519.
  • 3
    Gertz MA, Lacy M, Dispenzieri A. Amyloidosis. Hematology – Oncology Clinics of North America 1999;13:121133.
  • 4
    Kyle RA & Gertz MA. Primary systemic amyloidosis: Clinical laboratory features in 474 cases. Semin Hematol 1995;32:4559.
  • 5
    Gravallese E, Baker N, Lester S, Kay J, Owen WF. Musculoskeletal manifestations in β2-microglobulin amyloidosis. Arthritis Rheum 1992;35:592602.
  • 6
    Cunningham BA, Wang JL, Berggård I, Peterson PA. The complete amino acid sequence of β2-microglobulin. Biochemistry 1973;12:481122.
  • 7
    Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987;329:50612.
  • 8
    Pras M, Schubert M, Zucker-Franklin D, Rimon A, Franklin EC. The characterization of soluble amyloid prepared in water. J Clin Invest 1968;47:92433.
  • 9
    Schägger H & Von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987;166:36879.
  • 10
    Hamidi Asl L, Liepnieks JJ, Hamidi Asl K et al. Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol 1999;154:2217.
  • 11
    Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C. Sequences of Proteins of Immunological Interest. 5th edn. Vol 1 NIH, Bethesda, MD, 1991:11827.
  • 12
    Epp O, Lattman EE, Schiffer M, Huber R, Palm W. The molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI refined at 2.0-Å resolution. Biochemistry 1975;14:494352.
  • 13
    Huang DB, Chang CH, Ainsworth C et al. Comparison of crystal structures of two homologous proteins: structural origin of altered domain interactions in immunoglobulin light-chain dimers. Biochemistry 1994;33:1484857.
  • 14
    Schormann N, Murrell JR, Liepnieks JJ, Benson MD. Tertiary structure of an amyloid immunoglobulin light chain protein: a proposed model for amyloid fibril formation. Proc Natl Acad Sci USA 1995;92:94904.
  • 15
    Toft KG, Olstad OK, Sletten K et al. Comparative studies of two AL chains of kappa-III light chain origin with and without attached carbohydrate (AL So124 and AL 700). In: NatvigJB, et al. eds. Amyloid and Amyloidosis 1990. Vith International Symposium on Amyloidosis, August 5–8, Oslo, Norway. Dordrecht/Boston/London: Kluwer Academic Publishers, 1990:16972.
  • 16
    Engvig JP, Olsen KE, Gislefoss RE, Sletten K, Wahlström O, Westermark P. Constant region of a κIII immunoglobulin light chain as a major AL-amyloid protein. Scand J Immunol 1998;48:928.
  • 17
    Pras M, Itzchaki M, Prelli F, Dollberg L, Frangione B. Amyloid arthropathy: characterization of the amyloid protein. Clin Exp Rheumatol 1985;3:32731.
  • 18
    Picken MM, Gallo GR, Pruzanski W, Frangione B. Biochemical characterization of amyloid derived from the variable region of the κ light chain subgroup III. Arthritis Rheum 1990;33:8804.
  • 19
    Pons-Estel B, Goñi F, Solomon A, Frangione B. Sequence similarities among κIIIb chains of monoclonal human IgMκ autoantibodies. J Exp Med 1984;160:893904.